Skip to Content
Merck
  • Alterations in oligodendrocyte transcriptional networks reveal region-specific vulnerabilities to neurological disease.

Alterations in oligodendrocyte transcriptional networks reveal region-specific vulnerabilities to neurological disease.

iScience (2023-03-31)
Dario Tommasini, Rachel Fox, Kathie J Ngo, Jason D Hinman, Brent L Fogel
ABSTRACT

Neurological disease is characterized the by dysfunction of specific neuroanatomical regions. To determine whether region-specific vulnerabilities have a transcriptional basis at cell-type-specific resolution, we analyzed gene expression in mouse oligodendrocytes across various brain regions. Oligodendrocyte transcriptomes cluster in an anatomical arrangement along the rostrocaudal axis. Moreover, regional oligodendrocyte populations preferentially regulate genes implicated in diseases that target their region of origin. Systems-level analyses identify five region-specific co-expression networks representing distinct molecular pathways in oligodendrocytes. The cortical network exhibits alterations in mouse models of intellectual disability and epilepsy, the cerebellar network in ataxia, and the spinal network in multiple sclerosis. Bioinformatic analyses reveal potential molecular regulators of these networks, which were confirmed to modulate network expression in vitro in human oligodendroglioma cells, including reversal of the disease-associated transcriptional effects of a pathogenic Spinocerebellar ataxia type 1 allele. These findings identify targetable region-specific vulnerabilities to neurological disease mediated by oligodendrocytes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
PRT4165, ≥98% (HPLC)